Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk
Sponsor: Aktiia SA
Summary
Because Aktiia S.A. has been the first-ever company to put in the market an Optical Blood Pressure Monitoring device, there is a need for Aktiia S.A. to correlate for the first time continual Blood Pressure monitoring and the evolution of environmental and health factors to improve hypertension management.
Official title: OBPM_FORESEE2024: Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk in a Multi-ethnic European Population: an Observational Cohorts' Study
Key Details
Gender
All
Age Range
21 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
15000
Start Date
2025-05-12
Completion Date
2035-05-31
Last Updated
2025-05-14
Healthy Volunteers
Yes
Interventions
Lifestyle survey completion
For the next 10 years, starting at their inclusion in the research project and every 6 months thereafter: fill in an online survey on their lifestyle- health- socioeconomic environment. The completion of a survey lasts 5min maximum.
Unlimited on-demand blood pressure measurements with G2C
For the next 10 years: take unlimited on-demand measurements with the Aktiia G2C feature (finger measurement) while seated
Continual blood pressure measurements with G1
For the next 10 years: wear their 24/7 Aktiia G1 device continuously as they would outside the context of the research project.
Locations (2)
Fully remote study- no physical investigational site
Lausanne, Switzerland
Fully remote study- no physical investigational site
London, United Kingdom